CLSA Board of Directors
William J. Newell
Chief Executive Officer, Sutro Biopharma, Inc.
Global Head, Johnson & Johnson Innovation, JLABS
Executive Vice President, Corporate Affairs and Chief Communications Officer, Allergan
Bruce W. Jenett
Senior Counsel, DLA Piper LLP (US)
Partner, Covington & Burling LLP
Chief Executive Officer OncoCyte
Michael V. Arbige, Ph.D.
Vice President of R&D, DuPont Biosciences
Senior Vice President, Managed Markets, Takeda Pharmaceuticals USA
Worldwide President, Medication Management Solutions, Becton, Dickinson And Company (BD)
David Beier, J.D.
Managing Director, Bay City Capital
Senior Vice President, Government Affairs, Genentech
Ho Sung Cho
Vice President, Biotherapeutics, Celgene
Peter J. Claude
David H. Crean
Managing Director & Partner, Objective Capital Partners
Principal, Healthcare and Life Sciences, KPMG
Chief Financial Officer, Gossamer Bio
President and Chief Executive Officer, Nkarta Therapeutics
Vice President, Head of Oncology Discovery and Early Development, AbbVie, Inc.
Vice President, Government Relations and Public Affairs, Pfizer
President and CEO, Ambys Medicines
Steve A. Kay, Ph.D., D.Sc.
Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California
Larry Kwak, M.D., Ph.D.
Vice President and Cancer Center Associate Director
Director, Toni Stephenson Lymphoma Center
Corporate Vice President, Public Affairs, Edwards Lifesciences
Principal, Life Science Practice, Deloitte
President and Chief Executive Officer, CytomX
Shlomo Melmed, MB, ChB, MACP
Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System
Director, President and Chief Executive Officer, Amyris
Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP
Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline
Founder, CEO, and Chairman, Viscient Biosciences
President and Chief Executive Officer, Codexis
Christian W. Nolet
Partner and Life Sciences Industry Leader, West Region, Ernst & Young
Joshua J. Ofman M.D., M.S.H.S
Senior Vice President, Global Value, Access & Policy, Amgen
Michael G. Raab
President and Chief Executive Officer, Ardelyx
Ganesh Raman, Ph.D.
Associate Vice Chancellor for Research, California State University
Co-Chief Executive Officer, Alexandria Real Estate (ARE)
Partner, Hogan Lovells US LLP
President & CEO, Blade Therapeutics
Daria Mochly-Rosen, Ph.D.
The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine
Terry Rosen, Ph.D.
Chief Executive Officer, Arcus Biosciences
George Savage M.D.
Co-Founder, Chief Medical Officer, Proteus Digital Health
President, Medtronic Japan
Head of West Coast Business Development & Licensing, Merck
Harold E. Van Wart, Ph.D.
Jens Vogel, Ph.D.
President and CEO | Boehringer Ingelheim
Senior Vice President, Diabetes Care, Abbott
Rick E Winningham
Chairman and CEO, Theravance Biopharma